ERBB2 and glioblastoma: Additionally, 17 patients with progressive HER2-positive glioblastoma were treated in a phase 1 trial with peripheral blood infusions of autologous T cells specific for CMV, EBV, or adenovirus and genetically modified to express HER2-CARs [118].